{
    "nctId": "NCT00535509",
    "briefTitle": "Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel \u00b1 Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer",
    "officialTitle": "Phase II Trial of Neoadjuvant[FEC100]/Cisplatin-Docetaxel \u00b1 Trastuzumab in Women With Over Expressed or Amplified Her2/Neu With Locally Advanced Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 285,
    "primaryOutcomeMeasure": "Efficacy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with locally advanced breast cancer",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}